What is "high risk?" a systematic review of atopy risk and implications for primary prevention

Sarah L Chamlin1, Kellee Kaulback, Anthony J Mancini

  • 1Division of Pediatric Dermatology, Children's Memorial Hospital, Chicago, Illinois 60614, USA. schamlin@childrensmemorial.org

Pediatric Dermatology
|August 27, 2009
PubMed

Insights

Identifying high-risk children for atopic diseases is crucial for prevention. Current methods are highly variable, highlighting the need for a standardized, validated screening tool to improve early detection and intervention strategies.

Area of Science:

  • Pediatrics
  • Allergy and Immunology
  • Public Health

Background:

  • Atopic diseases, such as asthma and eczema, are increasingly prevalent worldwide.
  • Primary prevention strategies focus on identifying and intervening in high-risk children.
  • Existing methods for identifying high-risk children in atopy prevention studies lack standardization.

Purpose of the Study:

  • To evaluate the diverse methodologies employed to identify high-risk children within atopy prevention research.
  • To assess the commonalities and variations in risk identification techniques used in published studies.

Main Methods:

  • A comprehensive literature search was conducted for studies published between 1986 and 2006.
  • Abstracts were screened, followed by a detailed review of selected articles.
  • Fifty-seven studies met the inclusion criteria for analysis of risk identification methods.

Main Results:

  • Thirty distinct methods were identified for defining high risk in children.
  • Family history of atopy was the most frequently used predictor.
  • Only a minority of studies utilized validated questionnaires for family history assessment; others relied solely on reported history.

Conclusions:

  • The current approaches to identifying children at high risk for atopic diseases are inconsistent.
  • There is a significant need for the development and implementation of a practical, validated screening tool for early identification.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...